Medicare Enrolled
Dr. David Packey, M.D. PH.D
Neurology · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Packey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Packey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Packey
Dr. David Packey is a neurology specialist in Melbourne, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Packey performed 52,136 Medicare services across 1,682 unique beneficiaries.
Between the years covered by Open Payments, Dr. Packey received a total of $10,604 from 61 pharmaceutical and/or device companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Packey is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in FL
$10,604 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 66496 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗52,136
Medicare services
Top 1% in FL for neurology
1,682
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,607 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
49,732 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,140 | $91 | $200 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
177 | $70 | $180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
173 | $56 | $125 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
136 | $123 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $117 | $300 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 99 | $58 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $132 | $300 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
66 | $133 | $375 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
55 | $107 | $260 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
49 | $94 | $200 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
39 | $140 | $350 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
39 | $156 | $450 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
31 | $220 | $600 |
| New patient office visit, complex (60-74 min) | 29 | $155 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $137 | $375 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
25 | $288 | $700 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
25 | $99 | $300 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
22 | $56 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $59 | $150 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
17 | $86 | $250 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
11 | $40 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,604
Total received (2018-2024)
Avg $1,515/year across 7 years
Top 27% in FL for neurology
61
Companies
608
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,183 (96.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$241 (2.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,580
2023
$1,674
2022
$1,209
2021
$1,638
2020
$990
2019
$1,922
2018
$1,591
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$948
UCB, Inc.
$768
Novartis Pharmaceuticals Corporation
$626
Biogen, Inc.
$578
ABBVIE INC.
$527
GENZYME CORPORATION
$458
Amgen Inc.
$455
Alexion Pharmaceuticals, Inc.
$405
PFIZER INC.
$403
EMD Serono, Inc.
$375
Eisai Inc.
$333
ARGENX US, INC.
$266
Biohaven Pharmaceuticals, Inc.
$260
AbbVie Inc.
$257
Sunovion Pharmaceuticals Inc.
$235
Neurelis, Inc.
$230
SK Life Science, Inc.
$221
NOVARTIS PHARMACEUTICALS CORPORATION
$195
Lilly USA, LLC
$193
Allergan Inc.
$192
EISAI INC.
$191
Acorda Therapeutics, Inc
$180
Kyowa Kirin, Inc.
$166
ACADIA Pharmaceuticals Inc
$160
Biohaven Pharmaceutical Holding Company Ltd.
$144
Neurocrine Biosciences, Inc.
$143
Genentech USA, Inc.
$124
Allergan, Inc.
$107
Lundbeck LLC
$103
Sumitomo Pharma America, Inc.
$102
Otsuka America Pharmaceutical, Inc.
$100
US WorldMeds, LLC
$95
CSL Behring
$84
Avanir Pharmaceuticals, Inc.
$81
SCILEX PHARMACEUTICALS INC.
$72
Celgene Corporation
$68
Adamas Pharmaceuticals, Inc.
$65
Ipsen Biopharmaceuticals, Inc
$58
Amneal Pharmaceuticals LLC
$57
LivaNova USA, Inc.
$54
Mallinckrodt Enterprises LLC
$45
JAZZ PHARMACEUTICALS INC.
$42
Corium, LLC
$42
Takeda Pharmaceuticals U.S.A., Inc.
$40
Greenwich Biosciences, Inc.
$31
Averitas Pharma Inc.
$29
Harmony Biosciences LLC
$27
Grifols USA, LLC
$27
Supernus Pharmaceuticals, Inc.
$24
TG Therapeutics, Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
Janssen Pharmaceuticals, Inc
$22
Azurity Pharmaceuticals, Inc.
$21
Merz Pharmaceuticals, LLC
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Mallinckrodt LLC
$18
Impax Laboratories, Inc.
$16
BioMarin Pharmaceutical Inc.
$16
Merz North America, Inc.
$15
Mallinckrodt Hospital Products Inc.
$13
GRT US Holding, Inc.
$12
Top 3 companies account for 22.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · Azstarys · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Brineura · Briviact · COMIRNATY · COPAXONE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONFI · ONPATTRO · Privigen · QELBREE · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TRINTELLIX · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XEOMIN · Xadago · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $20 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
30
Per 100K population
4.8
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Packey is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Packey experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Packey performed 49,732 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Packey receive payments from pharmaceutical companies?
Yes. Dr. Packey received a total of $10,604 from 61 companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Packey's costs compare to other neurologists in Melbourne?
Dr. Packey's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Packey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Melbourne
Browse neurologists in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology